Monique Elseviers
Biographic Data
| ID | 7503520 |
|---|---|
| NAME | Monique Elseviers |
| GIVEN NAMES | Monique |
| FAMILY NAME | Elseviers |
| SIGNATURE | ELSEVIERS M |
| AFFILIATIONS | Ghent University Hospital |
| ORCID | 0000-0001-9415-6900 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Data transparency for building a stronger healthcare system
In order to compile an inventory of national data sources for drug utilization research (DUR) in Argentina and to verify publicly available data sources, we performed a cross-sectional study that sought to identify national and provincial databases of drug use. In July 2020, we searched the websites of government institutions, carried out a systematic query of bibliographic databases for “drug utilization research” conducted in Argentina, and con…
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
Regulatory reliance has become a common practice in the LAC region. Thirteen out of 20 regulators directly recognize or abbreviate the marketing authorization process in case of earlier approval by a regulator from another jurisdiction. The regulators most relied upon are the European Medicines Agency, United States Food and Drug Administration, and Health Canada
No prominent works on this page.
Data transparency for building a stronger healthcare system
In order to compile an inventory of national data sources for drug utilization research (DUR) in Argentina and to verify publicly available data sources, we performed a cross-sectional study that sought to identify national and provincial databases of drug use. In July 2020, we searched the websites of government institutions, carried out a systematic query of bibliographic databases for “drug utilization research” conducted in Argentina, and con…
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
Regulatory reliance has become a common practice in the LAC region. Thirteen out of 20 regulators directly recognize or abbreviate the marketing authorization process in case of earlier approval by a regulator from another jurisdiction. The regulators most relied upon are the European Medicines Agency, United States Food and Drug Administration, and Health Canada
Business (2 works) · Medicine (2 works) · Political science (2 works) · Accounting (1 work) · Agency (philosophy (1 work) · Antibiotic Use and Resistance (1 work) · Audit (1 work) · Authorization (1 work) · Biomedical Ethics and Regulation (1 work) · Biosimilars and Bioanalytical Methods (1 work)